查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298856

连续血糖监测系统市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球连续血糖监测系统的市场规模达到61亿美元。展望未来，IMARC集团预计到2028年市场规模将达到86亿美元，在2023-2028年期间表现出5.7%的增长率（CAGR）。

连续葡萄糖监测系统（CGMS）是技术先进的设备，可以自动跟踪血糖水平。它们由一个发射器集成的传感器组成，通过经皮或皮下途径发挥作用，连续测量间质中的葡萄糖浓度。然后发射器将信息发送到一个可以夹在衣服上的无线监测器。连续葡萄糖监测系统有助于提供糖尿病的完整概况，提醒血糖水平的高低，检测模式，并增加病人对身体活动、药物选择、食物份量和压力的了解。与传统的葡萄糖监测设备相比，CGMS是无刺的，因为它们可以放在皮肤上，从而有助于以快速和无痛的方式提供实时信息。

连续葡萄糖监测系统的市场趋势：

全球范围内的老年人口不断增加，他们更容易患上糖尿病，这给市场带来了积极的前景。CGMS通常用于测量体内的葡萄糖和胰岛素水平，如果下降或上升到一个危险的水平，就会进一步发出警报。与此相应，广泛利用产品来实时识别低血糖和高血糖的情况，有利于市场增长。此外，帮助检测糖尿病患者的糖化血红蛋白（Hb1ac）的CGMS的重大改进和新技术进步正在为市场增长提供相当大的推动力。此外，人工胰腺设备系统与CGMS技术的整合，以泵送胰岛素和施用最佳剂量来管理病人的血糖水平，对市场增长产生了积极的影响。除此之外，非侵入性CGMS设备的引入作为一种方便的选择，广泛的研究和开发（R&D）活动以及对较少或微创的诊断工具的需求增加，预计将进一步推动市场的增长。

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球连续血糖监测系统市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按组件分類的市场

  • 传感器
    • 市场趋势
    • 市场预测
  • 发射器和接收器
    • 市场趋势
    • 市场预测
  • 集成式胰岛素泵
    • 市场趋势
    • 市场预测

第7章 ：按人口统计学分類的市场

  • 儿童人口（≤14岁）
    • 市场趋势
    • 市场预测
  • 成人人口（大于14岁）
    • 市场趋势
    • 市场预测

第8章：按终端用户分類的市场

  • 诊所和诊断中心
    • 市场趋势
    • 市场预测
  • ICU
    • 市场趋势
    • 市场预测
  • 家庭保健
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • A. Menarini Diagnostics S.r.l.
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc. (Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112023A5377

The global continuous glucose monitoring systems market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors

Transmitters and Receivers

Integrated Insulin Pumps

Breakup by Demographics:

Child Population (≤14 years)

Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers

ICUs

Home Healthcare

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report1. What was the size of the global continuous glucose monitoring systems market in 2022?

2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2023-2028?

3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?

4. What are the key factors driving the global continuous glucose monitoring systems market?

5. What is the breakup of the global continuous glucose monitoring systems market based on the component?

6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?

7. What is the breakup of the global continuous glucose monitoring systems market based on end user?

8. What are the key regions in the global continuous glucose monitoring systems market?

9. Who are the key players/companies in the global continuous glucose monitoring systems market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Continuous Glucose Monitoring Systems Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Component

  • 6.1  Sensors 
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Transmitters and Receivers 
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Demographics

  • 7.1  Child Population (≤14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5  Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7  Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10  Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12  Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2022
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2023-2028
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players